Profile picture

Doctor Vincenzo Castiglione

Fondazione Toscana Gabriele Monasterio, Pisa (Italy)
Membership: HFA Member
Follow
Biography
I am a cardiologist at Fondazione Toscana Gabriele Monasterio (Pisa) and a PhD student in Translational Medicine at Sant’Anna School of Advanced Studies (Pisa). I graduated in Medicine from the University of Pisa in 2017, and was also an Honour Course student at Sant’Anna School of Advanced Studies, from which I graduated in 2018. My research focuses mainly on heart failure and cardiomyopathies, particularly cardiac amyloidosis.
Logo ESC

Contributor content

18F-Florbetaben-PET/CT extracardiac uptake in patients with suspected cardiac amyloidosis: prevalence, distribution, and prognostic significance
Presentation
18F-Florbetaben-PET/CT extracardiac uptake in patients with suspected cardiac amyloidosis: prevalence, distribution, and prognostic significance
Serum transthyretin before and after starting tafamidis as outcome predictors in ATTR cardiomyopathy
Presentation
Serum transthyretin before and after starting tafamidis as outcome predictors in ATTR cardiomyopathy
Relative efficacy of tafamidis, acoramidis, patisiran and vutrisiran in patients with transthyretin cardiac amyloidosis: a network meta-analysis
Presentation
Relative efficacy of tafamidis, acoramidis, patisiran and vutrisiran in patients with transthyretin cardiac amyloidosis: a network meta-analysis
Plasma transthyretin fractions in transthyretin cardiac amyloidosis patients undergoing tafamidis treatment
Presentation
Plasma transthyretin fractions in transthyretin cardiac amyloidosis patients undergoing tafamidis treatment
Cardiac remodelling and sympathetic activation in cardiac amyloidosis: insights from transcardiac blood sampling
Presentation
Cardiac remodelling and sympathetic activation in cardiac amyloidosis: insights from transcardiac blood sampling
Relative efficacy of tafamidis, acoramidis, patisiran and vutrisiran in patients with transthyretin cardiac amyloidosis: a network meta-analysis
Presentation
Relative efficacy of tafamidis, acoramidis, patisiran and vutrisiran in patients with transthyretin cardiac amyloidosis: a network meta-analysis
Chest pain after elective percutaneous coronary intervention as trigger of Takotsubo syndrome
Presentation
Chest pain after elective percutaneous coronary intervention as trigger of Takotsubo syndrome
Incidence and clinical characteristics of cardiac amyloidosis in Tuscany and Umbria
Presentation
Incidence and clinical characteristics of cardiac amyloidosis in Tuscany and Umbria
Biohumoral and echocardiographic correlates of tafamidis treatment in transthyretin cardiac amyloidosis
Presentation
Biohumoral and echocardiographic correlates of tafamidis treatment in transthyretin cardiac amyloidosis
Prognostic value of sST2 in  heart failure patients with diabetes
Presentation
Prognostic value of sST2 in heart failure patients with diabetes

ESC 365 is supported by